Several major manufacturing plants for the asthma and respiratory drug Albuterol have shut down, possibly worsening an already-flaring shortage of the medication that has forced hospitals to devise ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...

One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.

Medically reviewed by Daniel More, MD Key Takeaways Asthma action plans help maintain good asthma control by outlining ...

LAKE FOREST, Ill. -- An ongoing shortage of a medicine commonly used to treat people with breathing problems is expected to get worse after a major supplier to US hospitals shut down last week, CNN ...

A multiyear community asthma program on the Navajo Nation increased asthma-related care and awareness among families, even as ...

A new study published in the journal of BMJ Thorax showed that inhaled corticosteroids (ICS) may enhance the respiratory ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...